Target Corp (TGT) Stock Price Quote, News & Filings

Summary

Target Corp. engages in the operation and ownership of general merchandise stores. It offers food and general merchandise, clothing and household goods, electronics, and toys. Its brands include A New Day, All in Motion, Art Class, Auden, AVA & VIV, Boots and Barkley, Brightroom, Bullseye's Playground, Casaluna, Cat & Jack, Cloud Island, Colsie, dealworthy, Embark, Everspring, Favorite Day, Figmint, Future Collective, Gigglescape, Good & Gather, Goodfellow & Co, Hearth & Hand with Magnolia, Heyday, Hyde & EEK! Boutique, JoyLab, Kindfull, Kona Sol, Made By Design, Market Pantry, Mondo Llama, More Than Magic, Opalhouse, Open Story, Original Use, Pillowfort, Project 62, Room Essentials, Shade & Shore, Smartly, Smith & Hawken, Sonia Kashuk, Spritz, Sun Squad, Threshold, Universal Thread, up&up, Wild Fable, Wondershop, Xhilaration, California Roots, Casa Cantina, The Collection, Headliner, Jingle & Mingle, Rosé Bae, Photograph, SunPop, and Wine Cube. The company was founded by George Draper Dayton in 1902 and is headquartered in Minneapolis, MN.

Website

corporate.target.com

Location

Minneapolis, MN, US

Phone612 304 6073

Employees415,000

CEOMichael J. Fiddelke

Sector

Consumer Discretionary

Industry

Broadline Retail

Ask AI

Company overview

Business model, segments, and competition.

Peer comparison

Metrics vs closest competitors.

Guidance & outlook

Forward guidance and assumptions.

Bull vs bear case

Upside drivers and key risks.

Valuation snapshot

Multiples vs history and peers.

Competitive moat

Defensibility and market position.

Management track record

Leadership and capital allocation history.

How it makes money

A short diagram of the business model.

Latest Documents

Mentions in Filings

… ns 85% of the corporation’s voting stock upon consummation of the transaction that made him or her an interested stockholder (excluding from the 85% calculation shares owned by directors who are also officers of the target corporation and shares held by employee stock plans that do not permit employees to decide confidentially whether to accept a tender or exchange offer); or (iii) at or after the time on which such stockholder becomes an interes …
Alaunos Therapeutics, Inc.Target Corp·PRE 14A - Preliminary proxy statement·Q4 26·05:30PM
… *PSUs*: The PSUs vest upon completion of the performance period and specific performance conditions set forth for each individual grant for individually defined reporting and operating measurement objectives. The Company determines the factor to be applied to that target number of PSUs, with such percentage based on level of achievement of the performance conditions. Upon the achievement of the conditions, any unvested PSUs become fully vested.
PERPETUA RESOURCES CORP.Target Corp·10-Q - Quarterly report Q3·Q3 26·05:29PM
… re revenue, projected costs, prospects, plans and objectives of management, are forward-looking statements. The words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “predict,” “project,” “target,” “potential,” “would,” “could,” “should,” “continue” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We may not a …
Nakamoto Inc.Target Corp·424B5 - Prospectus filing (Rule 424(b)(5))·Q4 26·05:29PM
… covenants under our borrowing arrangements, and the future liquidity of the Company. We generally identify forward-looking statements by terminology such as may, will, should, expects, plans, anticipates, could, intends, target, projects, “outlook,” contemplates, believes, estimates, predicts, potential or continue or the negative of these terms or other similar words. Forward-looking statements are based upon current plans, estimates and expect …
BCP Investment CorpTarget Corp·425 - Form 425 - Business combination communication·Q4 26·05:28PM
… All includes OPSCC (oropharyngeal) and non-OPSCC at 2.7 and 3.6 mg/kg; Corbus investor deck; (8) Pyxis press release, September 2026; (9) Best ORR = confirmed and/or unconfirmed responses; cORR = confirmed ORR. Molecule (Target Modality) MGC026(1) I-DXd(2) SYS6043(3) SKB500(4) Sacituzumab Govitecan(5) Telisotuzumab adizutecan(6) CRB-701 (SYS6002)(7) Micvotabart pelidotin(8) Target / Payload B7-H3 / Topo I B7-H3 / Topo I B7-H3 / Topo I B7-H3 / To …
MACROGENICS INCTarget Corp·EX-99.1 - 8-K - Regulation FD Disclosure·Q4 26·05:28PM
… repurchase, in each quarter, up to 5% of the NAV of the Company’s Common Shares outstanding (either by number of shares or aggregate NAV) as of the close of the previous calendar quarter. For the avoidance of doubt, such target amount is assessed each calendar quarter. The Board may amend or suspend the share repurchase program at any time (including to offer to purchase fewer shares) if in its reasonable judgment it deems such action to be in t …
TPG Twin Brook Capital Income FundTarget Corp·10-Q - Quarterly report Q3·Q3 26·05:28PM

Key Stats

Trading

Px/Chg 1D$156.00 / -0.45%

Prev Close$163.18

% of 52Wk H94.22%

Avg Volume5.56M

Beta0.29

Mkt Cap70.85B

FD Mkt Cap73.07B

Float

Shrs Out/Float454.19M / 452.79M

Short Float0.04%

Days to Cover3.63

Stock Repurchased$89.00M

Current Valuation

EV86.15B

EV/EBITDA10.71

EV/Sales0.81

P/B4.32

P/S0.67

FCF Yield-0.45%

ROE4.76%

ROA1.35%

Current Ratio0.93

Dividend

Cash$1.14

Yield3.75%

Yield (TTM)3.75%

Estimates

P/E20.54

Est P/E0.00

Est EPS1.47

Est PEG0.00

Valuation

Metric	5Yr Avg	May '23	May '24	May '25	May '26	Oct '26
PRICE-BASED RATIOS
Price / Earnings	39.46	23.40	16.71	10.68	55.77	90.72
Price / Sales	1.27	0.60	0.64	0.41	1.91	2.78
Price / Book Value	4.37	5.79	5.15	2.98	3.61	4.32
Price / Free Cash Flow	-42.36	-43.07	18.13	9.76	25.48	-222.11
ENTERPRISE VALUE METRICS
Enterprise Value	76,982.6	81,884.6	85,006.0	58,791.1	73,080.5	86,150.8
Enterprise Value / Sales	1.58	0.75	0.79	0.55	2.40	3.39
Enterprise Value / EBITDA	21.21	12.41	9.88	6.79	33.07	43.89
Enterprise Value / EBIT	34.58	21.02	14.66	10.37	51.94	74.91

Financials

Full Financials

Millions USD	5Yr CAGR (%)	Jan '22	Jan '23	Feb '24	Feb '25	Jan '26
INCOME STATEMENT
Revenue	-29%	106,005.0	109,120.0	107,412.0	106,566.0	104,780.0
Gross Income	-1.5%	31,042.0	26,814.0	29,584.0	30,064.0	29,269.0
EBITDA	-8.6%	11,970.0	6,596.0	8,600.0	8,653.0	8,346.0
EBIT	-13.5%	9,328.0	3,896.0	5,799.0	5,672.0	5,212.0
Net Income	-14.5%	6,946.0	2,780.0	4,138.0	4,091.0	3,705.0
EPS (Diluted)	-12.9%	14.10	5.98	8.94	8.86	8.13
BALANCE SHEET
Cash & ST Inv	-1.8%	5,911.0	2,229.0	3,805.0	4,762.0	5,488.0
Total Assets	2.5%	53,811.0	53,335.0	55,356.0	57,769.0	59,490.0
Total Liabilities	1.4%	40,984.0	42,103.0	41,924.0	43,103.0	43,325.0
Total Shareholder Equity	6%	12,827.0	11,232.0	13,432.0	14,666.0	16,165.0
CASH FLOW
Net Operating Cash Flow	-6.6%	8,625.0	4,018.0	8,621.0	7,367.0	6,562.0
Cap Ex	1.3%	-3,544.0	-5,528.0	-4,806.0	-2,891.0	-3,727.0
Free Cash Flow	-13.6%	5,081.0	-1,510.0	3,815.0	4,476.0	2,835.0

Enterprise Value Bridge

Millions USD		13 Nov '26
Price (As of 13 Nov '26)		160.78
Basic Shares		454.19
Market Cap		73,022.6
Diluted Shares		456.60
Fully Diluted Shares Outstanding		456.60
Fully Diluted Market Cap		73,409.9
+Consolidated Debt		18,701.0
−In-the-Money Convertible Debt		—
+Capital Leases		3,332.0
+Operating Leases		—
−Cash & Equivalents		-5,411.0
−Short-term Investments		-
+Total Preferred		-
−In-the-Money Convertible Preferred		—
−Investments in Unconsolidated Subs		—
+Non-Controlling Interest		-
+Pension Liabilities		—
Enterprise Value		86,312.6

Segment data

Revenue

by Products and services

Food & Beverage23%
Household Essentials17%
Hardlines15%
Apparel & Accessories15%
Home Furnishings & Decor15%